logo
Plus   Neg
Share
Email

GE Healthcare Releases Contrast-Enhanced Guided Biopsy Solution - Quick Facts

GE Healthcare, the healthcare business of GE (GE), announced the availability of Serena Bright, a contrast-enhanced guided biopsy solution, in the United States. The technology allows clinicians to conduct breast biopsy exams with contrast guidance using the same mammography equipment, in the same room and with the same staff as the screening or diagnostic mammogram. It received FDA 510(k) clearance in June.

Agnes Berzsenyi, CEO of Women's Health and X-Ray at GE Healthcare, said: "We hope this technology can help improve breast cancer outcomes for women during this time of uncertainty."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walmart Inc. has launched a nationwide drive to boost COVID-19 vaccination rates by reaching out to more residents in vulnerable communities. The retail giant will organize a series of community events at 43 locations in 18 states to administer the COVID-19 vaccine. Walmart said it plans to continue these new events over the next several weeks as vaccine allocations allow. Pfizer Inc. (PFE) and OPKO Health Inc. (OPK) announced Friday that the European Medicines Agency or EMA has validated for review the Marketing Authorization Application for somatrogon. Pfizer expects a decision from the European Commission in 2022. The company said somatrogon is a long-acting recombinant... German telecom giant Deutsche Telekom AG reported Friday strong growth in fourth-quarter profit mainly driven by T-Mobile US results following the takeover of the competitor Sprint. Looking ahead for fiscal 2021, the company projects higher adjusted EBITDA AL, a key earnings metric.
Follow RTT